C–X–C motif chemokine ligand (CXCL)9/10/11 are known as T cell chemoattractants, which recruit anti-tumor cytotoxic T lymphocytes via its receptor C–X–C chemokine receptor 3 and inhibit tumor progression20–22. Here, CXCL9 is linked to neoplasm.